Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Control Trial of MuST Technique for Vascular Access Cannulation in Hemodialysis Patients: Contributions for a Safe Nursing Intervention

NCT05081648 is registered in ClinicalTrials.gov with Fresenius Medical Care Deutschland GmbH as lead sponsor.

NCT NCT05081648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05081648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Control Trial of MuST Technique for Vascular Access Cannulation in Hemodialysis Patients: Contributions for a Safe Nursing Intervention
Lead sponsor
Fresenius Medical Care Deutschland GmbH
Phase
Not applicable
Overall status
Completed
Start date
January 3, 2022
Completion date
April 30, 2023
Enrollment
101 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

arteriovenous fistula, chronic kidney diseases, hemodialysis, hemodialysis access failure, vascular access complication